Literature DB >> 8702762

The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase.

C E Cooper1, G R Lynagh, K P Hoyes, R C Hider, R Cammack, J B Porter.   

Abstract

The depletion of cellular iron can lead to the inhibition of ribonucleotide reductase, preventing new DNA synthesis and hence inhibiting cell proliferation. Electron paramagnetic resonance (EPR) spectroscopy has been used to examine simultaneously for the first time the relationship between chelation of intracellular iron and the rate of removal and regeneration of the tyrosyl radical of ribonucleotide reductase within intact human leukemia K562 cells. The different physiochemical characteristics of relatively hydrophobic low molecular weight bidentate hydroxypyridinone chelators and the higher molecular weight hexadentate ferrioxamine have been exploited to elucidate these interactions further. The base-line concentration of EPR-detectable mononuclear nonheme iron complexes was 3.15 =/- 1.05 microM, rising on incubation with chelators more rapidly with hydroxypyridinones than with desferrioxamine. Hydroxypyridinones also removed the tyrosyl radical more rapidly, apparently as a consequence of depletion of the intracellular iron pools necessary to regenerate the active enzyme and compatible with their reportedly greater cell toxicity. The radical decay rate is consistent with previous models, suggesting that iron is spontaneously removed from mammalian ribonucleotide reductase. Upon removal of extracellular chelator the regeneration of the tyrosyl radical was significantly faster for hydroxypyridinones than for desferrioxamine, consistent with their differential effects on cell cycle synchronization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702762     DOI: 10.1074/jbc.271.34.20291

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Cellular adaptation to down-regulated iron transport into lymphoid leukaemic cells: effects on the expression of the gene for ribonucleotide reductase.

Authors:  C R Chitambar; J P Wereley; T Heiman; W E Antholine; W J O'brien
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Ferritin expression modulates cell cycle dynamics and cell responsiveness to H-ras-induced growth via expansion of the labile iron pool.

Authors:  Or Kakhlon; Yosef Gruenbaum; Z Ioav Cabantchik
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

3.  Type IV secretion machinery promotes ton-independent intracellular survival of Neisseria gonorrhoeae within cervical epithelial cells.

Authors:  Tracey A Zola; Heather R Strange; Nadia M Dominguez; Joseph P Dillard; Cynthia N Cornelissen
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

Review 4.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

Review 5.  The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.

Authors:  Alessandra Gaeta; Robert C Hider
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

6.  Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.

Authors:  Patricia Evans; Reem Kayyali; Robert C Hider; John Eccleston; John B Porter
Journal:  Transl Res       Date:  2010-05-27       Impact factor: 7.012

7.  A computational model of intracellular oxygen sensing by hypoxia-inducible factor HIF1 alpha.

Authors:  Amina A Qutub; Aleksander S Popel
Journal:  J Cell Sci       Date:  2006-08-15       Impact factor: 5.285

8.  Disulfide-masked iron prochelators: Effects on cell death, proliferation, and hemoglobin production.

Authors:  E A Akam; R D Utterback; J R Marcero; H A Dailey; E Tomat
Journal:  J Inorg Biochem       Date:  2018-01-04       Impact factor: 4.155

9.  Exogenous ferrous iron is required for the nitric oxide-catalysed destruction of the iron-sulphur centre in adrenodoxin.

Authors:  Nina V Voevodskaya; Vladimir A Serezhenkov; Chris E Cooper; Lioudmila N Kubrina; Anatoly F Vanin
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

Review 10.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.